Researchers from the University of Liverpool have developed a framework for AI to improve antimicrobial use and infection care, helping to address the global challenge of antimicrobial resistance (AMR).
Their blueprint is detailed in a research paper published today in the journal The Lancet Digital Health titled Antimicrobial Learning Systems: An Implementation Blueprint for Artificial Intelligence to Tackle Antimicrobial Resistance.
Lead author Dr Alex Howard said: “Different forms of AI bring many opportunities to improve healthcare.
“AIs can harness complex evolving data, inform and augment human actions, and learn from outcomes.
“The global public health challenge of AMR needs large-scale optimisation of antimicrobial use and wider infection care, which can be enabled by carefully constructed AIs.”
The researchers noted that while AI has become increasingly useful and robust, healthcare systems remain challenging places for their deployment – and an implementation gap exists between the promise of AIs and their use in patient and population care.
With this in mind, the researchers have outlined an adaptive implementation and maintenance framework for AIs to improve antimicrobial use and infection care as a learning system.
This considers AMR problem identification, law/regulation, organisational support and data processing in relation to AMR-targeted AI development, assessment, maintenance and scalability.
Dr Howard said: “Bridging the implementation gap between AI innovation and tackling AMR presents technical, regulatory, organisational, and human challenges.
“Learning systems built on integrated dataflows, governance, and technologies have the potential to close this gap.
“Translational expertise between AMR and AI fields will be essential to appropriately design, maintain, normalise, and globalise AMR-AIs in infection care and realise the potential for AIs to support clinician-driven AMR minimisation strategies.”
The research articulates a vision of how data science can be leveraged to tackle antimicrobial resistance as part of the Centres for Antimicrobial Optimisation Network programme, a global collaborative bringing together world-leading multidisciplinary expertise in infection and health informatics.
